# Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients

> **NCT00711230** · PHASE2 · COMPLETED · sponsor: **Genetic Immunity** · enrollment: 36 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **BIOLOGICAL:** DermaVir
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00711230
- **Lead sponsor:** Genetic Immunity
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2011-12
- **Final completion:** 2015-01-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2020-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00711230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00711230, "Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00711230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*